第1頁(yè):2017年考研英語(yǔ)閱讀理解考前沖刺試題第十四套
第2頁(yè):考研各科目歷年真題匯總(2016-2011)
第3頁(yè):2017年考研熱點(diǎn)資訊推薦
第4頁(yè):2017考研英語(yǔ)模擬試題
第5頁(yè):2017考研英語(yǔ)備考輔導(dǎo)
A widely heralded but still experimental cancer-fighting compound may be used someday to prevent two other major killers of Americans: heart disease and stroke. That was the implication of a remarkable report published last week in the journal Circulation by a team of researchers from Dr. Judah Folkman's laboratory at the Children's Hospital in Boston.
The versatile compound is endostatin, a human protein that inhibits angiogenesis, the growth of new blood vessels in the body. In tests reported in 1997 by Folkman, a prominent cancer researcher who pioneered the study of angiogenesis, the drug had reduced and even eradicated tumors in laboratory mice. How? By stunting the growth of capillaries necessary for nourishing the burgeoning mouse tumors.
When news of Folkman's achievement became widely known last year, it led to wildly exaggerated predictions of imminent cancer cures. When other scientists were initially unable to duplicate those results, questions arose about the validity of Folkman's research. Then in February scientists at the National Cancer Institute, with guidance from Folkman, finally matched his results. Reassured, the N.C.I. gave the go-ahead for clinical trials of endostatin later this year on patients with advanced tumors.
How can a drug that is apparently effective against tumors also reduce the risk of heart attack and stroke? The answer lies in the composition of plaque, the fatty deposit that builds up in arteries and can eventually clog them. Plaque consists of a mix of cholesterol, white blood cells and smooth muscle cells, and as it accumulates, a network of capillaries sprouts from the artery walls to nourish the cells. Could endostatin halt the growth of capillaries and starve the plaque?
A Folkman lab team led by Dr. Karen Moulton decided to find out. The scientists put baby lab mice on a 16-week “Western diet” that was high in fat and cholesterol, then measured the plaque buildup on the walls of each aorta, the large artery that carries blood from the heart to the rest of the body. Meanwhile, they injected one group of mice with endostatin, another with a different blood-vessel inhibitor called TNP-470 and a control group with an inert saline solution. Twenty weeks later the researchers again measured plaque in the mouse aortas. The results were startling: the endostatin group averaged 85% less plaque buildup and the TNP-470 group 70% less than those in the control group.
All too aware of the premature hopes raised last year after Folkman's tumor report, the researchers have been careful not to oversell the new results. “If this finding is supported in future studies,” says Moulton, “[it could open the way for] treatments that could delay the progression of heart disease and possibly reduce the incidence of heart attacks and strokes.” But any such treatments, she stresses, are probably five to 10 years away.
注(1):本文選自Time; 04/19/99, p48;
注(2):本文習(xí)題命題模仿對(duì)象2004年真題Text 1;
1. What did the report indicate?
[A]A very important drug is now at experimental stage.
[B]Heart disease and stroke are the most serious threats to Americans.
[C]The tumor drug can be used for the heart disease in the future.
[D]Many Americans suffer from heart disease and stroke.
2. Why did the N.C.I. agree to have clinical trials of endostatin on the patients?
[A]They were convinced of the Folkman's research.
[B]They can do such a research as well as Folkman.
[C]The patients with advanced tumors need the drug.
[D]The drug should be proved effective on humans.
3. The expression “stunting the growth of capillaries”(Line 8, Paragraph 2) most probably
means _______.
[A]help the growth of capillaries
[B]limit the growth of capillaries
[C]improve the growth of capillaries
[D]prevent the growth of capillaries
4. Why can the tumor drug be used for the heart?
[A]It can accumulate a network of capillaries and nourish the cells.
[B]It can stop the growth of capillaries and provide no nourishment for plaque.
[C]The curing method of tumor and heart disease is the same.
[D]The tumor and heart disease are made up of the same substance.
5. Which of the following is true according to the text?
[A]Folkman's tumor report had been exaggerated.
[B]The tumor drug is not as effective as what has been expected.
[C]The new results of the research are far more encouraging.
[D]Researchers still have a long way to go to make another successful experiment.
答案:CADBC
初級(jí)會(huì)計(jì)職稱(chēng)中級(jí)會(huì)計(jì)職稱(chēng)經(jīng)濟(jì)師注冊(cè)會(huì)計(jì)師證券從業(yè)銀行從業(yè)會(huì)計(jì)實(shí)操統(tǒng)計(jì)師審計(jì)師高級(jí)會(huì)計(jì)師基金從業(yè)資格稅務(wù)師資產(chǎn)評(píng)估師國(guó)際內(nèi)審師ACCA/CAT價(jià)格鑒證師統(tǒng)計(jì)資格從業(yè)
一級(jí)建造師二級(jí)建造師消防工程師造價(jià)工程師土建職稱(chēng)房地產(chǎn)經(jīng)紀(jì)人公路檢測(cè)工程師建筑八大員注冊(cè)建筑師二級(jí)造價(jià)師監(jiān)理工程師咨詢(xún)工程師房地產(chǎn)估價(jià)師 城鄉(xiāng)規(guī)劃師結(jié)構(gòu)工程師巖土工程師安全工程師設(shè)備監(jiān)理師環(huán)境影響評(píng)價(jià)土地登記代理公路造價(jià)師公路監(jiān)理師化工工程師暖通工程師給排水工程師計(jì)量工程師
人力資源考試教師資格考試出版專(zhuān)業(yè)資格健康管理師導(dǎo)游考試社會(huì)工作者司法考試職稱(chēng)計(jì)算機(jī)營(yíng)養(yǎng)師心理咨詢(xún)師育嬰師事業(yè)單位教師招聘公務(wù)員公選考試招警考試選調(diào)生村官
執(zhí)業(yè)藥師執(zhí)業(yè)醫(yī)師衛(wèi)生資格考試衛(wèi)生高級(jí)職稱(chēng)護(hù)士資格證初級(jí)護(hù)師主管護(hù)師住院醫(yī)師臨床執(zhí)業(yè)醫(yī)師臨床助理醫(yī)師中醫(yī)執(zhí)業(yè)醫(yī)師中醫(yī)助理醫(yī)師中西醫(yī)醫(yī)師中西醫(yī)助理口腔執(zhí)業(yè)醫(yī)師口腔助理醫(yī)師公共衛(wèi)生醫(yī)師公衛(wèi)助理醫(yī)師實(shí)踐技能內(nèi)科主治醫(yī)師外科主治醫(yī)師中醫(yī)內(nèi)科主治兒科主治醫(yī)師婦產(chǎn)科醫(yī)師西藥士/師中藥士/師臨床檢驗(yàn)技師臨床醫(yī)學(xué)理論中醫(yī)理論